Posted by Michael Wonder on 28 Apr 2026
Broken PBS system behind failure to list Mounjaro for type 2 diabetics, according to Medicines Australia
28 April 2026 - Hundreds of thousands of Australians with diabetes will continue paying thousands of dollars a year for lifesaving medication not on the PBS, because of the "broken" process behind subsidising medicines, according to the peak industry body.
The PBAC recommended tirzepatide — an injectable GLP-1 medication sold as Mounjaro — be subsidised for adults with "inadequately controlled" type 2 diabetes mellitus.
